Canada markets closed

Cytokinetics, Incorporated (CYTK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
65.27+0.93 (+1.45%)
At close: 04:00PM EDT
66.38 +1.11 (+1.70%)
After hours: 04:31PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
7,530
7,530
94,588
70,428
55,828
Cost of Revenue
330,123
330,123
240,813
159,938
96,951
Gross Profit
-322,593
-322,593
-146,225
-89,510
-41,123
Operating Expenses
Research Development
-
-
-
159,938
96,951
Selling General and Administrative
173,612
173,612
177,977
96,803
52,820
Total Operating Expenses
173,612
173,612
177,977
96,803
52,820
Operating Income or Loss
-496,205
-496,205
-324,202
-186,313
-93,943
Interest Expense
57,668
57,668
51,156
29,332
38,676
Total Other Income/Expenses Net
-
-
-24,939
-
-
Income Before Tax
-526,244
-526,244
-388,955
-215,314
-127,290
Income Tax Expense
0
-
-
-
-
Income from Continuing Operations
-526,244
-526,244
-388,955
-215,314
-127,290
Net Income
-526,244
-526,244
-388,955
-215,314
-127,290
Net Income available to common shareholders
-526,244
-526,244
-388,955
-215,314
-127,290
Basic EPS
-2.80
-5.45
-4.33
-2.80
-1.97
Diluted EPS
-2.80
-5.45
-4.33
-2.80
-1.97
Basic Average Shares
76,886
96,524
89,825
76,886
64,524
Diluted Average Shares
76,886
96,524
89,825
76,886
64,524